- Home
- CLIR vs CVKD Comparison
CLIR vs CVKD Comparison
Compare CLIR & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLIR
- CVKD
- Stock Information
- Founded
- CLIR 2008
- CVKD 2022
- Country
- CLIR United States
- CVKD United States
- Employees
- CLIR N/A
- CVKD N/A
- Industry
- CLIR Industrial Machinery/Components
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- CLIR Industrials
- CVKD Health Care
- Exchange
- CLIR Nasdaq
- CVKD Nasdaq
- Market Cap
- CLIR 27.9M
- CVKD 29.5M
- IPO Year
- CLIR 2012
- CVKD 2023
- Fundamental
- Price
- CLIR $0.54
- CVKD $12.54
- Analyst Decision
- CLIR Strong Buy
- CVKD Strong Buy
- Analyst Count
- CLIR 1
- CVKD 1
- Target Price
- CLIR $2.00
- CVKD $32.00
- AVG Volume (30 Days)
- CLIR 55.2K
- CVKD 36.2K
- Earning Date
- CLIR 08-13-2025
- CVKD 08-06-2025
- Dividend Yield
- CLIR N/A
- CVKD N/A
- EPS Growth
- CLIR N/A
- CVKD N/A
- EPS
- CLIR N/A
- CVKD N/A
- Revenue
- CLIR $2,895,000.00
- CVKD N/A
- Revenue This Year
- CLIR $27.61
- CVKD N/A
- Revenue Next Year
- CLIR $116.19
- CVKD N/A
- P/E Ratio
- CLIR N/A
- CVKD N/A
- Revenue Growth
- CLIR 10.88
- CVKD N/A
- 52 Week Low
- CLIR $0.46
- CVKD $5.70
- 52 Week High
- CLIR $1.72
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- CLIR 38.87
- CVKD 49.98
- Support Level
- CLIR $0.50
- CVKD $11.00
- Resistance Level
- CLIR $0.60
- CVKD $13.56
- Average True Range (ATR)
- CLIR 0.06
- CVKD 1.15
- MACD
- CLIR -0.00
- CVKD 0.25
- Stochastic Oscillator
- CLIR 26.77
- CVKD 80.97
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.